Tuesday, 4 February, 2025

Veeda Clinical Research Refiles DRHP with SEBI for IPO

Veeda Clinical Research has refiled its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to raise funds through an Initial Public Offering (IPO). The IPO comprises a fresh issue of shares up to ₹185 crore and an offer-for-sale of up to 13 million equity shares by promoters and other selling shareholders. Proceeds will be used for capital expenditure, subsidiary investments, debt repayment, and business growth.